Table 3– Serious adverse events (SAEs)#
All patientsCompleted studyCV-CV+
Subjects96805129
≥1 SAE19 (20)11 (14)6 (12)5 (17)
Type of events
 Pneumothorax8642
 COPD exacerbation7413
 Pneumonia1110
 Dyspnoea1101
 Respiratory failure1000
 Death2000
  • Data are presented as n or n (%). CV-: collateral ventilation absent; CV+: collateral ventilation present; COPD: chronic obstructive pulmonary disease. #: >1 SAE per patient is possible.